The autoimmune hepatitis market is estimated to be valued at USD 134.7 Mn in 2025 and is expected to reach USD 199.9 Mn by 2032, growing at a compound annual growth rate (CAGR) of 5.8% from 2025 to 2032. https://timessquarereporter.com/news/autoimmune-hepatitis-market-poised-for-growth-with-targeted-immunotherapies